Symbiotic Sciences Private Limited, a active private limited company, was established on 23 February 2007 in New Delhi, Delhi, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100DL2007PTC159662. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹1.28 Cr.
Formerly known as Symbiotic Science Private Limited. It upholds a compliant status. Employing 10 professional, Its leadership includes Vivek Malhotra (Director), Asha Malhotra (Director), Rakesh Malhotra (Director). Past directors included Vivek Malhotra, Harikant Saxena, Dinesh Kumar. It holds ₹24.82 Cr open charges and ₹11.88 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at G 6 Ground Floor, Saket, New Delhi, Delhi, 110017.
U73100DL2007PTC159662
159662
23 February 2007
₹4.50 Cr
₹1.28 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Symbiotic Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Malhotra | Director | 27 Jul 2015 | Current |
| Asha Malhotra | Director | 23 Feb 2007 | Current |
| Rakesh Malhotra | Director | 24 Feb 2010 | Current |
| Aditya Malhotra | Director | 01 Nov 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Oct 2008 | Past |
| Pramod Abcsdd | Director | 10 Jun 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Symbiotic Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.48% increase. The company also saw a slight improvement in profitability, with a 6.39% increase in profit. The company's net worth Soared by an impressive increase of 12.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Symbiotic Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹248,231,050.00
₹118,765,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2025 | Sidbi | ₹1.00 Cr | Open |
| 11 Jun 2025 | Canara Bank | ₹2.50 M | Open |
| 29 Mar 2025 | Sidbi | ₹1.00 Cr | Open |
| 29 Mar 2025 | Sidbi | ₹3.00 Cr | Open |
| 05 Mar 2025 | Canara Bank | ₹1.80 M | Open |
Explore comprehensive loan charge details -
Symbiotic Sciences has a workforce of 10 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Symbiotic Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiotic Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 15 Jun 2022 via Charge ID 100588820 with Canara Bank was fully satisfied on 19 Dec 2025. was completed.
Progress on A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 101188528 was registered on 19 Nov 2025. was documented.
Progress on Symbiotic Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 101118365 was registered on 11 Jun 2025. was completed.
The activity Symbiotic Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 101076613 was registered on 29 Mar 2025. was recorded as a recent event.
The CIN of Symbiotic Sciences Private Limited is U73100DL2007PTC159662.
Symbiotic Sciences Private Limited is headquartered at G 6 Ground Floor, Saket, New Delhi, Delhi, 110017.
Symbiotic Sciences Private Limited was incorporated on 23 February 2007.
The current directors of Symbiotic Sciences Private Limited are
The primary industry of Symbiotic Sciences Private Limited is Professional, Scientific And Technical.
Symbiotic Sciences Private Limited is unlisted.
The authorized capital of Symbiotic Sciences Private Limited is ₹4.50 Cr, and the paid-up capital is ₹1.28 Cr.
The compliance status of Symbiotic Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX